Skip to content
Heavy Metal Index

Health risk implications of heavy metals in toothpaste

Overview

This Short Communication is a screening-level health risk assessment, not a primary occurrence study. The authors, three Stantec environmental consultants, take a 50-toothpaste lead/cadmium/mercury/arsenic concentration dataset publicized in a 2025 Guardian news article (the underlying testing was performed by Lead Safe Mama, a consumer-advocacy lead-poisoning-prevention business) and convert it to age-stratified ingestion exposure estimates using a standard EPA-style ADD/LADD framework, then compare to health guidance values (HGVs) via hazard quotients. Cadmium and mercury hazard quotients stay below 1.0 for all 50 toothpastes under both typical and reasonable-upper-bound use scenarios. Lead exceeds the OEHHA Proposition 65 MADL of 0.5 µg/day in 10 toothpastes for children aged 2–4 and 1 toothpaste for adults under reasonable-upper-bound use, and in 1 children’s toothpaste under typical use. Arsenic lifetime-average daily dose exceeds the EPA IRIS oral cancer slope factor benchmark in 3 toothpastes. The authors conclude that, contextualised against dietary lead intake, dust/soil ingestion, and dietary arsenic intake, toothpaste ingestion is unlikely to be a significant marginal contributor to total exposure; however, the upper-tail lead exceedances in children’s toothpastes flag a real concern that the paper itself addresses by endorsing the Washington State Toxic-Free Cosmetics Act 1000 ppb lead (Pb) cap.

Key numbers

Dataset (third-party testing, not measured by this paper): 50 toothpastes plus 3 tooth powders tested by Lead Safe Mama and reported via Perkins (2025) in The Guardian. Most products had detectable lead; cadmium, mercury, and arsenic were detected at lower product frequencies. Only 5 products had non-detectable concentrations for all four metals (source’s Supplementary file Table S1). The 3 tooth powders (products #50, #52, #53) were excluded from the present risk assessment; the 50 toothpastes (numbered 1–49 plus #51) are the analysed set.

Exposure model assumptions (Methods narrative pp. 2–3, Limitations p. 7–8):

  • Children aged 2–4 years: mean ingestion 0.30 g per brushing; 90th percentile ingestion 0.73 g per brushing (Barnhart et al. 1974, the four-age-group dentifrice ingestion study cited as the source dataset for the RIVM Cosmetics Fact Sheet). Table 1 gives one children’s toothpaste a typical lead average daily dose of 1.01e-2 µg/day and an upper-bound dose of 2.45e-2 µg/day. Two brushings per day (this brushing-frequency parameter is stated in the source’s Supplementary file, which was not accessed for this ingest; the main text only refers generically to “number of brushings per day”).
  • Adults aged 20–35 years: mean ingestion 0.04 g per brushing (Barnhart et al. 1974). Two brushings per day (same Supplementary file caveat).
  • The paper also reviews alternative child ingestion estimates from the literature, citing 0.205, 0.125, and 0.135 g per brushing in age groups 2–4, 5–7, and 8–12 years respectively (Strittholt et al. 2016), and 27.6% (Hargreaves et al. 1972) and 35.5% (Naccache et al. 1990) of the applied amount in children. These alternative estimates are described, not used as the model defaults.
  • CDC-recommended use for children 3–6 years is “no more than a pea-sized amount” (0.25 g) per brushing; for children <3 years a “smear of a rice grain” (Thornton-Evans et al. 2019). The model’s 0.30 g mean exceeds the CDC pea-sized recommendation by 1.2× and the 0.73 g 90th percentile exceeds it by 2.9×. The authors flag this as the main conservatism in their assessment.

Health guidance values (HGVs) used:

  • Pb: 0.5 µg/day Maximum Allowable Dose Level (MADL) from California OEHHA Proposition 65, derived to be protective of developmental effects in children and pregnant women. The authors note this is 4.4× lower than the FDA Interim Reference Level (IRL) of 2.2 µg/day for children and 8.8 µg/day for women of child-bearing age (the source states the IRL values without an age-band qualifier on the children value), both anchored on the CDC blood lead reference value (BLRV) of 3.5 µg/dL with a 10× safety factor (Price et al. 2023). The 1–3 year age band appears in the source attached to the dietary Pb intake values (mean 1.7 µg/day, 90th percentile 2.6 µg/day) used downstream for contextualisation, not to the IRL itself.
  • cadmium (Cd), total mercury (tHg): HGV values not stated in the main text; the source’s Supplementary file (not accessed for this ingest) carries the numerical HGVs used. The Cd and mercury (Hg) ADDs are reported as all below their respective HGVs at HQ < 1.0 for all 50 toothpastes under both use scenarios.
  • total arsenic (tAs): EPA IRIS oral cancer slope factor (CSF) for inorganic arsenic, applied to the lifetime average daily dose. The authors flag that the underlying testing did not speciate inorganic arsenic (iAs) vs tAs, so applying the iAs-specific CSF to the unspeciated arsenic measurements is itself conservative (likely an overestimate for any arsenic fraction that is organic).

Per-product exposure doses (selected from Table 1, pp. 3–5 of the source; full table runs all 50 products under typical and reasonable-upper-bound use scenarios):

Product #Children Pb (µg/day) typicalChildren Cd (µg/day) typicalChildren tHg (µg/day) typicalAdult Pb (µg/day) typicaltAs lifetime (µg/kg/day) typical
11.50E-031.50E-031.50E-032.00E-041.68E-05
133.41E-023.08E-024.50E-034.55E-034.23E-04
251.17E-011.58E-021.50E-031.57E-021.80E-04
371.75E-011.74E-026.60E-032.34E-029.20E-04
452.74E-017.50E-037.50E-033.66E-026.78E-04
493.41E-011.50E-038.76E-034.54E-029.57E-05
51 (outlier)2.10E+001.86E-021.50E-032.80E-019.07E-03

Range of children’s Pb ADDs across the 50 products: typical use 1.50E-03 to 2.10E+00 µg/day (three orders of magnitude); reasonable-upper-bound use 3.65E-03 to 5.11E+00 µg/day. Product #51 is the upper-tail outlier driving the range; the source notes only one toothpaste in the dataset had a measured Pb concentration exceeding 1000 ppb (consistent with that single product being #51).

HGV exceedance counts (Results, p. 2 and Figure 1; numerical values in Supplementary file Table S4):

  • Cd: zero exceedances for any product, age group, or use scenario (HQ < 1.0 throughout).
  • tHg: zero exceedances for any product, age group, or use scenario (HQ < 1.0 throughout).
  • Pb, children 2–4 years: 1 toothpaste exceeds under typical use (product #51); 10 toothpastes exceed under reasonable-upper-bound use (products #41, #42, #43, #44, #45, #46, #47, #48, #49, #51 per Figure 1).
  • Pb, adults 20–35 years: 1 toothpaste exceeds under reasonable-upper-bound use (product #51); zero exceedances under typical use.
  • tAs: 3 toothpastes exceed the LADD-based HGV under typical use (products #37, #45, #51 per Figure 1). Upper-bound LADDs could not be calculated because 90th-percentile toothpaste ingestion rates were not available beyond the 2–4 and 20–35 age groups (Table 1 footnote).

Contextualisation against dietary intakes (pp. 6–7):

  • Children’s dietary Pb intake (Price et al. 2023): mean 1.7 µg/day, 90th percentile 2.6 µg/day for children 1–3 years. With the exception of product #51 (Pb ADD 2.10 µg/day typical use, 5.11 µg/day upper-bound use), the 10 exceeding-toothpaste Pb ADDs are markedly lower than these dietary intakes.
  • Children’s dust/soil Pb exposure (Zartarian et al. 2017; ATSDR 2020): median dust 72 µg/g and 95th percentile dust 320 µg/g, median soil 26 µg/g and 95th percentile soil 426 µg/g; with baseline child dust ingestion 0.2 g/day and pica-level soil ingestion up to 5 g/day, this gives 95th-percentile Pb intakes of 64 µg/day from dust and 2130 µg/day from soil — three to four orders of magnitude above the toothpaste-ingestion estimates.
  • Adult Pb ADD (product #51, the only adult exceedance): 0.84 µg/day, which is 10.5× lower than the FDA IRL of 8.8 µg/day for women of child-bearing age. On a per-kg basis (70 kg body weight) this equals 0.012 µg/kg/day, 42× lower than the EFSA-reported mean dietary Pb intake of 0.5 µg/kg/day for European adults ≥18 years (EFSA 2012).
  • Arsenic LADDs exceeding the HGV (products #37 9.20E-04, #45 6.78E-04, #51 9.07E-03 µg/kg/day) are several orders of magnitude lower than the ATSDR mean daily dietary arsenic intake range of 0.31–1.80 µg/kg/day across age groups (ATSDR 2007).

Regulatory benchmarks cited:

  • Washington State Toxic-Free Cosmetics Act (TFCA) statutory limit for Pb in cosmetics: 1000 ppb. The Washington Department of Ecology interim policy (2024) acknowledges this limit “can be difficult, if not impossible, to achieve in some products” but the authors argue it is appropriate for children’s toothpastes given the dataset’s upper-tail. Only product #51 exceeds 1000 ppb Pb in the dataset.
  • FDA cosmetics action level for Pb: 10000 ppb (10 ppm). The source’s Table 2 maps this to a 5 µg/day Pb intake and a 0.8 µg/dL incremental blood lead increase (23% of BLRV) under the pea-sized-twice-daily scenario.
  • FDA Closer-to-Zero baby-food Pb action levels: 10 ppb (fruits/vegetables/mixtures/yogurt/meat), 20 ppb (single-ingredient root vegetables, dry infant cereals). These translate to modelled 90th-percentile Pb intakes of 0.23–0.62 µg/day, consistent with not exceeding the 2.2 µg/day IRL when summed across food categories.

Methods (brief)

Risk-assessment framework: standard EPA-style screening-level health risk assessment (HRA), with most-sensitive-endpoint selection (non-cancer endpoints for Pb, Cd, tHg; lifetime cancer endpoint for inorganic arsenic). For Pb, Cd, tHg, average daily dose ADD = (metal concentration in toothpaste) × (toothpaste ingestion rate) × (number of brushings per day), reported in µg/day. For arsenic (As), lifetime average daily dose LADD = (As concentration) × (toothpaste ingestion rate) × (brushings/day) × (annual exposure duration) × (lifetime exposure duration) / (body weight × lifetime), reported in µg/kg/day. Hazard quotient HQ = ADD/HGV (or LADD/HGV); HQ > 1.0 flags potential health risk.

Source dataset: third-party testing of 50 toothpastes commissioned by Lead Safe Mama, publicized via Perkins (2025) in The Guardian (cite ref 6). The present paper does not re-analyse the toothpaste samples or measure new concentrations; it takes the published concentrations at face value and runs the exposure-and-risk-characterisation arithmetic. The source notes the third-party testing did not disclose the analytical laboratory, the specific testing methods, or chain-of-custody details — flagged as a key data-quality limitation in the Strengths and limitations section.

Speciation: The Lead Safe Mama testing did not speciate inorganic vs total arsenic. The authors apply the EPA IRIS inorganic-arsenic cancer slope factor to the total-arsenic measurements as a conservative default. Mercury species (organic vs inorganic) is similarly not speciated in the source data; the paper records tHg.

Limitations the authors state (Strengths and limitations, pp. 7–8): (1) toothpaste ingestion rate is the main model conservatism (0.30 g mean exceeds CDC pea-sized 0.25 g by 1.2×); a sensitivity analysis substituting 0.25 g per brushing leaves only 1 Pb exceedance and 2 As exceedances; (2) HGVs are conservative selections (OEHHA MADL is 4.4× lower than FDA IRL for Pb; iAs CSF applied to unspeciated As overstates risk if organic As is present); (3) assumption that the same toothpaste brand is used over prolonged periods is unrealistic given likely consumer brand-switching; (4) dataset limitations from the third-party testing — single concentration per product (no replicates / no lot-to-lot variability data), unknown lab accreditation, unspecified analytical methods, unknown chain of custody.

Conflict-of-interest disclosure (source’s COI section, p. 10): all three authors are employed by Stantec, a consulting firm whose services include providing scientific advice to government, corporations, law firms, and various scientific/professional organisations. The disclosure states the firm “has previously been engaged by food and beverage companies, some of which produce products with ingredients that may contain lead, to provide general consulting and expert advice on scientific matters.” The paper is funded “no source of funding for this research” per the source; the authors report no competing interests related to the current work. The Stantec affiliation and prior food/beverage industry engagements are recorded here as evidence-weighting context for downstream synthesis.

Implications

Certification: This paper is direct-evidence on the Toothpaste (Cat 2) product category for the four HMTc analytes Pb, Cd, tHg, and tAs in the US market. The dataset’s chief signal is on lead in the upper tail of the children’s-toothpaste distribution: 10 of 50 toothpastes (20%) exceed the OEHHA-derived 0.5 µg/day Pb MADL under reasonable-upper-bound use in children aged 2–4, with one product (#51) exceeding by an order of magnitude even under typical use. Cadmium, mercury, and arsenic ADDs all stay well below health-guidance values. The Washington State Toxic-Free Cosmetics Act 1000 ppb Pb statutory limit is the operative US state-level binding limit for toothpaste; the authors endorse this limit as appropriate for children’s toothpastes. The source does not propose a HMTc certification threshold; this page does not propose one either. The paper-internal sensitivity analysis (reducing modelled ingestion from 0.30 g to 0.25 g per brushing reduces Pb exceedances from 10 to 1 in children) is relevant for downstream pooling-and-percentile work and is recorded here verbatim.

Courses: Useful as a methods case study for screening-level health risk assessment (ADD/LADD/HQ/HGV machinery), particularly for a Cat 2 toothpaste module addressing the brand-switching-vs-prolonged-use assumption and the rate-vs-concentration trade-off in exposure modelling. Useful as a case study in the conflict-of-interest weight question for industry-adjacent risk assessments. Useful as a worked example of dietary-and-environmental contextualisation (toothpaste Pb vs dietary Pb vs dust/soil Pb).

App: Toothpaste Pb concentration is the binding consumer-app signal for this product category. The paper provides the per-product Pb intake distribution (in µg/day) but does not provide the underlying per-product Pb concentrations (those are in the source’s Supplementary file Table S1, attached to brand names). Brand-attributed concentrations are not ingested onto this page; the distribution-level signal is sufficient for app routing.

Microbiome: Not applicable.

Update history

No substantive edit history is available in this build. The full commit record is available in git.